Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Altimmune, Inc. stock logo
ALT
Altimmune
$7.57
+1.3%
$9.39
$2.09
$14.84
$536.64M0.055.43 million shs3.12 million shs
Liberty All-Star Growth Fund, Inc. stock logo
ASG
Liberty All-Star Growth Fund
$5.16
+1.8%
$5.37
$4.47
$5.71
$300.52M1.33299,507 shs228,369 shs
Brompton Oil Split Corp. stock logo
OSP
Brompton Oil Split
C$2.99
C$2.48
C$5.14
C$2.86MN/A3,319 shs2,037 shs
Xtant Medical Holdings, Inc. stock logo
XTNT
Xtant Medical
$0.91
+8.3%
$0.00
$0.60
$1.45
$118.37M0.22146,200 shs86,064 shs
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Altimmune, Inc. stock logo
ALT
Altimmune
+1.34%+0.66%-16.63%-19.04%+37.14%
Liberty All-Star Growth Fund, Inc. stock logo
ASG
Liberty All-Star Growth Fund
+1.78%-0.48%-5.15%-0.77%+0.78%
Brompton Oil Split Corp. stock logo
OSP
Brompton Oil Split
0.00%0.00%0.00%+5.61%-32.66%
Xtant Medical Holdings, Inc. stock logo
XTNT
Xtant Medical
0.00%0.00%0.00%0.00%+131.37%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Altimmune, Inc. stock logo
ALT
Altimmune
1.6272 of 5 stars
3.32.00.00.03.21.70.0
Liberty All-Star Growth Fund, Inc. stock logo
ASG
Liberty All-Star Growth Fund
N/AN/AN/AN/AN/AN/AN/AN/A
Brompton Oil Split Corp. stock logo
OSP
Brompton Oil Split
N/AN/AN/AN/AN/AN/AN/AN/A
Xtant Medical Holdings, Inc. stock logo
XTNT
Xtant Medical
1.09 of 5 stars
3.53.00.00.00.01.70.0

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Altimmune, Inc. stock logo
ALT
Altimmune
2.67
Moderate Buy$15.0098.15% Upside
Liberty All-Star Growth Fund, Inc. stock logo
ASG
Liberty All-Star Growth Fund
N/AN/AN/AN/A
Brompton Oil Split Corp. stock logo
OSP
Brompton Oil Split
N/AN/AN/AN/A
Xtant Medical Holdings, Inc. stock logo
XTNT
Xtant Medical
3.00
Buy$1.6076.02% Upside

Current Analyst Ratings

Latest ADR, ASG, OSP, XTNT, and ALT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/1/2024
Altimmune, Inc. stock logo
ALT
Altimmune
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $12.00
3/28/2024
Altimmune, Inc. stock logo
ALT
Altimmune
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$20.00
2/13/2024
Altimmune, Inc. stock logo
ALT
Altimmune
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$20.00
1/24/2024
Altimmune, Inc. stock logo
ALT
Altimmune
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$13.00
(Data available from 4/24/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Altimmune, Inc. stock logo
ALT
Altimmune
$430K1,247.99N/AN/A$2.75 per share2.75
Liberty All-Star Growth Fund, Inc. stock logo
ASG
Liberty All-Star Growth Fund
N/AN/AN/AN/AN/AN/A
Brompton Oil Split Corp. stock logo
OSP
Brompton Oil Split
N/AN/AN/AN/AN/AN/A
Xtant Medical Holdings, Inc. stock logo
XTNT
Xtant Medical
$91.30M1.30$0.03 per share28.17$0.39 per share2.33

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Altimmune, Inc. stock logo
ALT
Altimmune
-$88.45M-$1.65N/AN/AN/A-20,780.75%-44.77%-40.72%5/9/2024 (Estimated)
Liberty All-Star Growth Fund, Inc. stock logo
ASG
Liberty All-Star Growth Fund
N/AN/A0.00N/AN/AN/AN/AN/A
Brompton Oil Split Corp. stock logo
OSP
Brompton Oil Split
N/A-C$0.40N/AN/AN/AN/AN/AN/AN/A
Xtant Medical Holdings, Inc. stock logo
XTNT
Xtant Medical
$660KN/A0.00N/A0.72%1.56%0.84%5/2/2024 (Estimated)

Latest ADR, ASG, OSP, XTNT, and ALT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/1/2024Q4 2023
Xtant Medical Holdings, Inc. stock logo
XTNT
Xtant Medical
N/A-$0.03-$0.03-$0.03N/A$28.11 million
3/27/2024Q4 2023
Altimmune, Inc. stock logo
ALT
Altimmune
-$0.35-$0.33+$0.02-$0.12N/A$0.04 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Altimmune, Inc. stock logo
ALT
Altimmune
N/AN/AN/AN/AN/A
Liberty All-Star Growth Fund, Inc. stock logo
ASG
Liberty All-Star Growth Fund
$0.448.53%-5.53%N/A1 Years
Brompton Oil Split Corp. stock logo
OSP
Brompton Oil Split
C$1.39N/AN/AN/A N/A
Xtant Medical Holdings, Inc. stock logo
XTNT
Xtant Medical
N/AN/AN/AN/AN/A

Latest ADR, ASG, OSP, XTNT, and ALT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/8/2024
Liberty All-Star Growth Fund, Inc. stock logo
ASG
Liberty All-Star Growth Fund
quarterly$0.127.9%4/18/20244/19/20246/3/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Altimmune, Inc. stock logo
ALT
Altimmune
N/A
17.26
17.26
Liberty All-Star Growth Fund, Inc. stock logo
ASG
Liberty All-Star Growth Fund
N/AN/AN/A
Brompton Oil Split Corp. stock logo
OSP
Brompton Oil Split
N/AN/AN/A
Xtant Medical Holdings, Inc. stock logo
XTNT
Xtant Medical
0.34
2.82
1.22

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Altimmune, Inc. stock logo
ALT
Altimmune
78.05%
Liberty All-Star Growth Fund, Inc. stock logo
ASG
Liberty All-Star Growth Fund
21.62%
Brompton Oil Split Corp. stock logo
OSP
Brompton Oil Split
N/A
Xtant Medical Holdings, Inc. stock logo
XTNT
Xtant Medical
69.33%

Insider Ownership

CompanyInsider Ownership
Altimmune, Inc. stock logo
ALT
Altimmune
4.10%
Liberty All-Star Growth Fund, Inc. stock logo
ASG
Liberty All-Star Growth Fund
0.32%
Brompton Oil Split Corp. stock logo
OSP
Brompton Oil Split
N/A
Xtant Medical Holdings, Inc. stock logo
XTNT
Xtant Medical
9.80%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Altimmune, Inc. stock logo
ALT
Altimmune
5970.89 million67.99 millionOptionable
Liberty All-Star Growth Fund, Inc. stock logo
ASG
Liberty All-Star Growth Fund
N/A58.24 million58.05 millionNot Optionable
Brompton Oil Split Corp. stock logo
OSP
Brompton Oil Split
N/A951,000N/ANot Optionable
Xtant Medical Holdings, Inc. stock logo
XTNT
Xtant Medical
207130.22 million117.46 millionNot Optionable

ADR, ASG, OSP, XTNT, and ALT Headlines

SourceHeadline
Xtant Medical (NYSEAMERICAN:XTNT) Stock Price Crosses Above Two Hundred Day Moving Average of $0.00Xtant Medical (NYSEAMERICAN:XTNT) Stock Price Crosses Above Two Hundred Day Moving Average of $0.00
americanbankingnews.com - April 19 at 3:22 AM
Xtant Medical Holdings, Inc. (AMEX:XTNT) Q4 2023 Earnings Call TranscriptXtant Medical Holdings, Inc. (AMEX:XTNT) Q4 2023 Earnings Call Transcript
finance.yahoo.com - April 2 at 12:47 PM
Q4 2023 Xtant Medical Holdings Inc Earnings CallQ4 2023 Xtant Medical Holdings Inc Earnings Call
finance.yahoo.com - April 2 at 2:17 AM
XTNT Stock Earnings: Xtant Medical Hldgs Misses EPS, Beats Revenue for Q4 2023XTNT Stock Earnings: Xtant Medical Hldgs Misses EPS, Beats Revenue for Q4 2023
investorplace.com - April 1 at 2:08 PM
Xtant Medical Holdings Inc (XTNT) Reports Record Revenue in 2023, Outpacing Analyst EstimatesXtant Medical Holdings Inc (XTNT) Reports Record Revenue in 2023, Outpacing Analyst Estimates
finance.yahoo.com - April 1 at 10:06 AM
Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 MillionXtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million
globenewswire.com - April 1 at 7:00 AM
Xtant Medical Holdings, Inc. (XTNT)Xtant Medical Holdings, Inc. (XTNT)
finance.yahoo.com - March 30 at 8:03 AM
Analysts Are Bullish on These Healthcare Stocks: Trulieve Cannabis (TCNNF), Xtant Medical Holdings (XTNT)Analysts Are Bullish on These Healthcare Stocks: Trulieve Cannabis (TCNNF), Xtant Medical Holdings (XTNT)
markets.businessinsider.com - March 28 at 3:54 PM
Xtant Medical to Issue Fourth Quarter and Full Year 2023 Financial Results on April 1, 2024Xtant Medical to Issue Fourth Quarter and Full Year 2023 Financial Results on April 1, 2024
globenewswire.com - March 21 at 4:05 PM
Xtant Medical boosts credit facility with MidCap FinancialXtant Medical boosts credit facility with MidCap Financial
beckersspine.com - March 8 at 3:10 PM
Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap FinancialXtant Medical Increases Revolving Credit Facility to $17 Million with MidCap Financial
globenewswire.com - March 7 at 4:05 PM
Xtant Medical to Present at the TD Cowen 44th Annual Healthcare ConferenceXtant Medical to Present at the TD Cowen 44th Annual Healthcare Conference
globenewswire.com - February 26 at 4:05 PM
Xtant Medical Hldgs Stock (AMEX:XTNT) Dividends: History, Yield and DatesXtant Medical Hldgs Stock (AMEX:XTNT) Dividends: History, Yield and Dates
benzinga.com - February 11 at 8:42 AM
Xtant Medical Holdings Inc [XTNT] Investment Guide: What You Need to KnowXtant Medical Holdings Inc [XTNT] Investment Guide: What You Need to Know
knoxdaily.com - January 1 at 9:25 AM
BTIG Keeps Their Buy Rating on Xtant Medical Holdings (XTNT)BTIG Keeps Their Buy Rating on Xtant Medical Holdings (XTNT)
markets.businessinsider.com - January 1 at 7:15 AM
BTIG Initiates Coverage of Xtant Medical Holdings (XTNT) with Buy RecommendationBTIG Initiates Coverage of Xtant Medical Holdings (XTNT) with Buy Recommendation
msn.com - December 6 at 5:03 PM
Xtant Medical Holdings (XTNT) Price Target Increased by 37.04% to 1.89Xtant Medical Holdings (XTNT) Price Target Increased by 37.04% to 1.89
msn.com - November 27 at 9:09 AM
Xtant Medical Holdings Inc XTNTXtant Medical Holdings Inc XTNT
morningstar.com - November 24 at 10:48 PM
Xtant Medical says chief commercial officer Brandt buys 41.7K shares in coXtant Medical says chief commercial officer Brandt buys 41.7K shares in co
msn.com - November 20 at 6:14 PM
Q3 2023 Xtant Medical Holdings Inc Earnings CallQ3 2023 Xtant Medical Holdings Inc Earnings Call
finance.yahoo.com - November 10 at 7:00 AM
Xtant Medical to Participate in Upcoming Investor ConferencesXtant Medical to Participate in Upcoming Investor Conferences
finance.yahoo.com - November 9 at 7:47 PM
Xtant Medical GAAP EPS of $0.07 beats by $0.09, revenue of $25.02M beats by $6.12MXtant Medical GAAP EPS of $0.07 beats by $0.09, revenue of $25.02M beats by $6.12M
msn.com - November 9 at 9:46 AM
Xtant Medical Announces Record Third Quarter Revenue of $25 MillionXtant Medical Announces Record Third Quarter Revenue of $25 Million
finance.yahoo.com - November 9 at 9:46 AM
Xtant Medical Holdings Inc (XTNT) Reports Record Q3 Revenue and Raises 2023 GuidanceXtant Medical Holdings Inc (XTNT) Reports Record Q3 Revenue and Raises 2023 Guidance
finance.yahoo.com - November 9 at 9:46 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Altimmune logo

Altimmune

NASDAQ:ALT
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.
Liberty All-Star Growth Fund logo

Liberty All-Star Growth Fund

NYSE:ASG
Liberty All-Star Growth Fund, Inc. is a closed-ended equity mutual fund launched and managed by ALPS Advisers, Inc. It is co-managed by Weatherbie Capital, LLC, Congress Asset Management Company, and Sustainable Growth Advisers, LP. The fund invests in the public equity markets of the United States. It seeks to invest in stocks of companies operating across diversified sectors. The fund primarily invests in growth stocks of companies across all market capitalizations. It employs fundamental analysis with a bottom-up stock picking approach to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Composite Index, Russell 3000 Growth Index, and the S&P 500 Index. It conducts in-house research to make its investments. The fund was previously known as Charles Allmon Trust, Inc. Liberty All-Star Growth Fund, Inc. was formed on March 14, 1986 and is domiciled in the United States.
Brompton Oil Split logo

Brompton Oil Split

TSE:OSP
Brompton Oil Split Corp. is a closed-ended equity mutual fund launched and managed by Brompton Funds Limited. The fund invests in public equity markets of North America. It primarily invests in dividend paying stocks of large-cap companies having market capitalization of at least $2 billion. The fund invests in stocks of companies which are a constituent of the S&P 500 Index and S&P/TSX Composite Index. It invests in stocks of companies operating in the oil and gas sectors. Brompton Oil Split Corp. was formed on February 24, 2015 and is domiciled in Canada.
Xtant Medical logo

Xtant Medical

NYSEAMERICAN:XTNT
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons. It offers OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSelect DBM Putty to mold into any shape and compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, a growth factor enriched cellular bone matrix; and nanOss family of products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, it offers Certex spinal fixation, Spider cervical plating, Streamline OCT, CervAlign, Axle interspinous fusion, Xpress minimally invasive pedicle screw, Fortex pedicle screw, Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation systems, and Silex sacroiliac joint fusion systems. Further, it provides Calix for cervical and thoracolumbar applications, as well as Irix-C Cervical Integrated Fusion, Irix-A Lumbar Integrated Fusion, Fortilink, and Irix-A Lumbar integrated fusion systems; Coflex device for lumbar spinal stenosis; and CoFix implant for back and disc pain. The company is headquartered in Belgrade, Montana.